Journal of Korean Neurosurgical Society

  • 제47권4호
  • /
  • Pages.258-264
  • /
  • 2010
  • /
  • 2005-3711(pISSN)
  • /
  • 1598-7876(eISSN)
대한신경외과학회 (The Korean Neurosurgical Society)
권호 표지
DOI QR코드

DOI QR Code

Treatment for Patients with Acute Ischemic Stroke Presenting beyond Six Hours of Ischemic Symptom Onset : Effectiveness of Intravenous Direct Thrombin Inhibitor, Argatroban

  • Park, Jung-Soo (Department of Neurosurgery, Research Institute of Clinical Medicine, Chonbuk National University Medical School and Hospital) ;
  • Park, Seung-Soo (Department of Neurosurgery, Research Institute of Clinical Medicine, Chonbuk National University Medical School and Hospital) ;
  • Koh, Eun-Jeong (Department of Neurosurgery, Research Institute of Clinical Medicine, Chonbuk National University Medical School and Hospital) ;
  • Eun, Jong-Pil (Department of Neurosurgery, Research Institute of Clinical Medicine, Chonbuk National University Medical School and Hospital) ;
  • Choi, Ha-Young (Department of Neurosurgery, Research Institute of Clinical Medicine, Chonbuk National University Medical School and Hospital)
  • 투고 : 2009.12.28
  • 심사 : 2010.03.29
  • 발행 : 2010.04.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objective : The objectives of this study were to analyze the outcome and hemorrhagic risk of intravenous (IV) argatroban in patients with acute ischemic stroke presenting beyond six hours of ischemic symptom onset. Methods : Eighty patients with acute ischemic stroke who were admitted to the hospital beyond six hours from ischemic symptom onset were retrospectively analyzed. We could not perform IV thrombolysis or intra-arterial thrombolysis because of limited time window. So, IV argatroban was performed to prevent recurrent thrombosis and progression of infarcted area. The outcome was assessed by the National Institute of Health Stroke Scale (NIHSS) score and related hemorrhagic risk was analyzed. Also, each outcome was analyzed according to the initial stroke severity, subtype, and location. Results : The median NIHSS was 8.0 at admission, 4.1 upon discharge, and 3.3 after three months. A good outcome was achieved in 81% of patients upon discharge and 88% after three months. Symptomatic hemorrhage occurred in only two patients (3%). IV argatroban was effective regardless of initial stroke severity, subtype, and location. Conclusion : IV argatroban may be an effective and safe treatment modality for acute ischemic stroke presenting beyond six hours of ischemic symptom onset.

키워드

참고문헌

  1. Adams HP Jr, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, et al. : Baseline NIH Stroke Scale score strongly predicts outcome after stroke : A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 53 : 126-131, 1999 https://doi.org/10.1212/WNL.53.1.126
  2. Biller J, Love BB, Marsh EE 3rd, Jones MP, Knepper LE, Jiang D, et al. : Spontaneous improvement after acute ischemic stroke. A pilot study. Stroke 21 : 1008-1012, 1990 https://doi.org/10.1161/01.STR.21.7.1008
  3. Escolar G, Bozzo J, Maragall S : Argatroban : a direct thrombin inhibitor with reliable and predictable anticoagulant actions. Drugs Today (Barc) 42 : 223-236, 2006 https://doi.org/10.1358/dot.2006.42.4.953588
  4. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. : Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study : a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282 : 2003-2011, 1999 https://doi.org/10.1001/jama.282.21.2003
  5. Gubitz G, Counsell C, Sandercock P, Signorini D : Anticoagulants for acute ischemic stroke. Cochrane Database Syst Rev : 2000;(2) : CD000024
  6. Hosomi N, Naya T, Kohno M, Kobayashi S, Koziol JA; Japan Standard Stroke Registry Study Group : Efficacy of anti-coagulant treatment with argatroban on cardioembolic stroke. J Neurol 254 : 605-612, 2007 https://doi.org/10.1007/s00415-006-0365-y
  7. Jorgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS : Factors delaying hospital admission in acute stroke : the Copenhagen Stroke Study. Neurology 47 : 383-387, 1996 https://doi.org/10.1212/WNL.47.2.383
  8. Jovin TG, Gupta R, Uchino K, Jungreis CA, Wechsler LR, Hammer MD, et al. : Emergent stenting of extracranial internal carotid artery occlusion in acute stroke has a high revascularization rate. Stroke 36 : 2426-2430, 2005 https://doi.org/10.1161/01.STR.0000185924.22918.51
  9. Kawai H, Yuki S, Sugimoto J, Tamao Y : Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J Pharmacol Exp Ther 278 : 780- 785, 1996
  10. Keris V, Rudnicka S, Vorona V, Enina G, Tilgale B, Fricbergs J : Combined intraarterial/intravenous thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 22 : 352-358, 2001
  11. Kobayashi S, Kitani M, Yamaguchi S, Suzuki T, Okada K, Tsunematsu T : Effects of an antithrombotic agent (MD-805) on progressing cerebral thrombosis. Thromb Res 53 : 305-317, 1989 https://doi.org/10.1016/0049-3848(89)90105-9
  12. Kobayashi S, Tazaki Y : Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis. Semin Thromb Hemost 23 : 531-534, 1997 https://doi.org/10.1055/s-2007-996131
  13. LaMonte MP : Argatroban in thrombotic stroke. Pathophysiol Haemost Thromb 32 Suppl 3 : 39-45, 2002 https://doi.org/10.1159/000069108
  14. LaMonte MP, Brown PM, Hursting MJ : Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor. Expert Rev Cardiovasc Ther 3 : 31-41, 2005 https://doi.org/10.1586/14779072.3.1.31
  15. LaMonte MP, Nash ML, Wang DZ, Woolfenden AR, Schultz J, Hursting MJ, et al. : Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1) : a randomized, placebo-controlled safety study. Stroke 35 : 1677-1682, 2004 https://doi.org/10.1161/01.STR.0000131549.20581.ba
  16. Morris DC, Zhang L, Zhang ZG, Lu M, Berens KL, Brown PM, et al. : Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke. Stroke 32 : 2635-2640, 2001 https://doi.org/10.1161/hs1101.097390
  17. Noser EA, Shaltoni HM, Hall CE, Alexandrov AV, Garami Z, Cacayorin ED, et al. : Aggressive mechanical clot disruption : a safe adjunct to thrombolytic therapy in acute stroke? Stroke 36 : 292- 296, 2005 https://doi.org/10.1161/01.STR.0000152331.93770.18
  18. Ok YC, Park SK, Cho KY, Lim JS, Lee RS : Epidemiology and characteristics of recurrent stroke : The occurrence type of restroke is similar as previous stroke. J Korean Neurosurg Soc 41 : 224-229, 2007 https://doi.org/10.3340/jkns.2007.41.4.224
  19. Park HS, Kang MJ, Huh JT : Recent epidemiological trends of stroke. J Korean Neurosurg Soc 43 : 16- 20, 2008 https://doi.org/10.3340/jkns.2008.43.1.16
  20. Sandercock PA, Counsell C, Kamal AK : Anticoagulants for acute ischemic stroke. Cochrane Database Syst Rev : 2008 oct 8;CD000024
  21. Saposnik G, Di Legge S, Webster F, Hachinski V : Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology 65 : 1169-1174, 2005 https://doi.org/10.1212/01.wnl.0000180687.75907.4b
  22. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group : N Engl J Med 333 : 1581-1587, 1995 https://doi.org/10.1056/NEJM199512143332401
  23. Toni D, Lorenzano S, Sacchetti ML, Fiorelli M, De Michele M, Principe M : Specific therapies for ischaemic stroke : rTPA and others. Neurol Sci 26 Suppl 1 : S26-S28, 2005 https://doi.org/10.1007/s10072-005-0399-4
  24. Urabe T, Tanaka R, Noda K, Mizuno Y : Anticoagulant therapy with a selective thrombin inhibitor for acute cerebral infarction : usefulness of coagulation markers for evaluation of efficacy. J Thromb Thrombolysis 13 : 155-160, 2002 https://doi.org/10.1023/A:1020426906956
  25. Wityk RJ, Pessin MS, Kaplan RF, Caplan LR : Serial assessment of acute stroke using the NIH Stroke Scale. Stroke 25 : 362-365, 1994 https://doi.org/10.1161/01.STR.25.2.362
  26. Yoneda Y, Mori E, Uehara T, Yamada O, Tabuchi M : Referral and care for acute ischemic stroke in a Japanese tertiary emergency hospital. Eur J Neurol 8 : 483-488, 2001 https://doi.org/10.1046/j.1468-1331.2001.00275.x

피인용 문헌

  1. Discovery, development and effectiveness of coagulation-inhibiting drugs for stroke therapy vol.6, pp.4, 2010, https://doi.org/10.1517/17460441.2011.563732